Metabolic regulators that permit adaptation to changes in caloric intake have been shown to be needed to protect from age-related disorders. Sirtuins play a crucial part in this program, impinging on not only aging but also other diseases. New findings are uncovering the multifaceted activity of sirtuins in living organisms and their effects on healthspan. In 'Bedside to Bench', Leonard Guarente discusses how different sirtuins are hindering cancer metabolism through suppression of the Warburg effect. The apparent antitumor effects of several sirtuins through their regulation of different metabolic pathways suggest therapeutic approaches to induce sirtuin function or that of downstream targets may block cancer growth. In 'Bench to Bedside', Eric Verdin peruses a few studies in different animal models showing that increased amounts of nicotinamide adenine dinucleotide (NAD), a cofactor of sirtuins, may have a positive effect in longevity and span of healthy life, or healthspan, by increasing sirtuin enzymatic activity. Whether harnessing NAD therapeutically is a potential way to extend lifespan and ameliorate diseases is still open to debate.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Upregulation of mitochondrial NAD+ levels impairs the clonogenicity of SSEA1+ glioblastoma tumor-initiating cells
Experimental & Molecular Medicine Open Access 09 June 2017
-
SIRT1 affects DNA methylation of polycomb group protein target genes, a hotspot of the epigenetic shift observed in ageing
Human Genomics Open Access 24 June 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Warburg, O., Wind, F. & Negelein, E. J. Gen. Physiol. 8, 519–530 (1927).
Ward, P.S. & Thompson, C.B. Cold Spring Harb. Perspect. Biol. 4, a006783 (2012).
Guarente, L. Genes Dev. 27, 2072–2085 (2013).
Sebastián, C. et al. Cell 151, 1185–1199 (2012).
Zhong, L. et al. Cell 140, 280–293 (2010).
Haigis, M.C. et al. Cell 126, 941–954 (2006).
Jeong, S.M. et al. Cancer Cell 23, 450–463 (2013).
Csibi, A. et al. Cell 153, 840–854 (2013).
Kim, H.S. et al. Cancer Cell 17, 41–52 (2010).
Verdin, E., Hirschey, M.D., Finley, L.W. & Haigis, M.C. Trends Biochem. Sci. 35, 669–675 (2010).
Bell, E.L., Emerling, B.M., Ricoult, S.J. & Guarente, L. Oncogene 30, 2986–2996 (2011).
Finley, L.W. et al. Cancer Cell 19, 416–428 (2011).
Hubbard, B.P. et al. Science 339, 1216–1219 (2013).
Feldman, J.L., Baeza, J. & Denu, J.M. J. Biol. Chem. 288, 31350–31356 (2013).
Wong, K.K., Engelman, J.A. & Cantley, L.C. Curr. Opin. Genet. Dev. 20, 87–90 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
L.G. has served as a consultant to GlaxoSmithKline and Chronos. He owns stock in Elysium Health and Segterra.
Rights and permissions
About this article
Cite this article
Guarente, L. The Many Faces of Sirtuins: Sirtuins and the Warburg effect. Nat Med 20, 24–25 (2014). https://doi.org/10.1038/nm.3438
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3438
This article is cited by
-
Upregulation of mitochondrial NAD+ levels impairs the clonogenicity of SSEA1+ glioblastoma tumor-initiating cells
Experimental & Molecular Medicine (2017)
-
Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma
Digestive Diseases and Sciences (2017)
-
SIRT1 affects DNA methylation of polycomb group protein target genes, a hotspot of the epigenetic shift observed in ageing
Human Genomics (2015)
-
Metabolic modulation of cancer: a new frontier with great translational potential
Journal of Molecular Medicine (2015)